VERU - Veru Inc. News

Sectors

VERU

Veru Inc.

2.30

1 x 2.29

1 x 2.31

bid

ask

0.04

1.71%

11:09 AM

timesize

Ytd	7.48%
1y	-59.65%

2.27

day range

2.32

2.05

52 week range

7.33

Open	2.32	Prev Close	2.34	Low	2.27	High	2.32	Mkt Cap	37.56M
Vol	40.36K	Avg Vol	1.96M	EPS	-1.49	P/E	-1.57	Forward P/E	-2.23
Beta	-1.19	Short Ratio	13.35	Inst. Own	42.04%	Dividend	N/A	Div Yield	N/A
Ex Div Date	04-28	Earning	08-12	50-d Avg	2.67	200-d Avg	2.65	1yr Est	3.40

VERU News

globenewswire.com

Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Da

MIAMI, FL, July 07, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

benzinga.com

Veru Strikes Clinical Supply Agreement With Novo Nordisk To Mull Combination Of Enobosarm With Wegov

https://www.sec.gov/ix?doc=/Archives/edgar/data/863894/000143774926019478/veru20260601_8k.htm

seekingalpha.com

Veru Inc. (VERU) Q2 2026 Earnings Call Prepared Remarks Transcript

benzinga.com

Earnings Scheduled For May 13, 2026

globenewswire.com

Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progre

--Phase 2b PLATEAU clinical study evaluating enobosarm + semaglutide is actively enrolling and on tr

globenewswire.com

Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th

MIAMI, FL, May 06, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharm

defenseworld.net

Veru (NASDAQ:VERU) Share Price Crosses Below 200 Day Moving Average – Here’s Why

Veru Inc. (NASDAQ: VERU - Get Free Report)'s stock price crossed below its 200-day moving average du

defenseworld.net

Veru (NASDAQ:VERU) Stock Passes Below 200 Day Moving Average – Should You Sell?

Veru Inc. (NASDAQ: VERU - Get Free Report) shares passed below its 200-day moving average during tra

defenseworld.net

Veru (NASDAQ:VERU) Shares Cross Below 200 Day Moving Average – Here’s Why

Veru Inc. (NASDAQ: VERU - Get Free Report)'s stock price passed below its 200-day moving average dur

globenewswire.com

Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combinati

-- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bo

seekingalpha.com

Veru Inc. (VERU) Q1 2026 Earnings Call Transcript

benzinga.com

Earnings Scheduled For February 11, 2026

defenseworld.net

Flora Growth (NASDAQ:FLGC) and Veru (NASDAQ:VERU) Financial Review

Veru (NASDAQ: VERU - Get Free Report) and Flora Growth (NASDAQ: FLGC - Get Free Report) are both sma

globenewswire.com

Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th

MIAMI, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

benzinga.com

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

seekingalpha.com

Veru Inc. (VERU) Q4 2025 Earnings Call Transcript

globenewswire.com

Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress

MIAMI, FL, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

benzinga.com

Earnings Scheduled For December 17, 2025

defenseworld.net

Veru (NASDAQ:VERU) Share Price Crosses Below Two Hundred Day Moving Average – Here’s Why

Veru Inc. (NASDAQ: VERU - Get Free Report) shares passed below its 200-day moving average during tra

benzinga.com

Top Stocks With Earnings This Week: Micron, FuelCell, Carnival and More

Investors are prepping for this week's earnings reports which include homebuilders, several appa

globenewswire.com

Veru to Report Fiscal Year 2025 Financial Results on December 17th

MIAMI, FL, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

globenewswire.com

Veru to Present Two Abstracts at ObesityWeek 2025

MIAMI, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

globenewswire.com

Veru Announces Proposed Public Offering

MIAMI, FL, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

globenewswire.com

Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preserva

MIAMI, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopha

zacks.com

Veru Announces Novel Modified-Release Oral Formulation for Enobosarm

VERU unveils a novel modified-release oral enobosarm to enhance fat loss while preserving lean mass

seekingalpha.com

Veru Inc. (VERU) Q3 2025 Earnings Call Transcript

Veru Inc. (NASDAQ:VERU ) Q3 2025 Earnings Call August 12, 2025 8:00 AM ET Company Participants K. Ga

benzinga.com

Earnings Scheduled For August 12, 2025

benzinga.com

Earnings Scheduled For May 8, 2025

benzinga.com

Earnings Scheduled For February 13, 2025

benzinga.com

Stocks That Hit 52-Week Lows On Wednesday

On Wednesday, 311 stocks hit new 52-week lows.

benzinga.com

Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday

Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media S

benzinga.com

99 Biggest Movers From Yesterday

Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday a

benzinga.com

Earnings Scheduled For August 12, 2021

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report

benzinga.com

77 Biggest Movers From Yesterday

Gainers Synthetic Biologics, Inc. (NYSE: SYN) shares climbed 100% to close at $1.00 on Tuesday af

benzinga.com

Stocks That Hit 52-Week Highs On Tuesday